XYLYX BIO Releases Highly Physiologic 2D Substrates for Improved Antifibrotic Drug Discovery

XYLYX BIO Releases Highly Physiologic 2D Substrates for Improved Antifibrotic Drug Discovery

Normal and fibrotic NativeCoat™ ECM substrates increase predictiveness of high throughput compound screening